ホーム › 多発性骨髄腫 › フロリダ州 › Miami

Miami、FLにおける多発性骨髄腫の臨床試験

Miamiとその周辺地域（約30マイル以内）の拠点で、多発性骨髄腫に関する21件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。

公式研究テキスト（英語）

ここで研究参加者を募集していますか？このページの上部に表示できます — 30日間 $99 →

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

被験者募集中第1/2相

University of Miami, Miami

18歳以上 · 全性別 · 2026/09/28更新 · NCT04973605

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

被験者募集中第2相

University of Miami Sylvester Comprehensive Cancer Center, Miami
University of Miami/Sylvester Cancer Institute - Alex's Place, Miami
University of Miami/Sylvester Cancer Institute - Griffin Cancer Research Building, Miami
他2件

12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535

ERd Combination Treatment in Newly Diagnosed Multiple Myeloma (ADVANCE 2.0)

被験者募集中第2相

University of Miami, Miami

18歳以上 · 全性別 · 2026/09/21更新 · NCT06997081

A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

被験者募集中第3相

University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami

18歳以上 · 全性別 · 2026/09/15更新 · NCT06615479

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

被験者募集中第2相

Miami Cancer Institute at Baptist Health, Inc., Miami

18歳以上 · 全性別 · 2026/09/14更新 · NCT06297226

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

被験者募集中第3相

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
University of Miami Hospital and Clinics, Miami
他3件

18歳以上 · 全性別 · 2026/08/24更新 · NCT06152575

A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments

被験者募集中第3相

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics, Miami
Sylvester Comprehensive Cancer Center - Kendall, Miami

18歳以上 · 全性別 · 2026/08/24更新 · NCT05020236

IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

被験者募集中第2相

University of Miami, Miami

18歳以上 · 全性別 · 2026/08/18更新 · NCT06376526

A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma

被験者募集中第1相

University of Miami Don Soffer Clinical Research Center, Miami

18歳以上 · 全性別 · 2026/08/18更新 · NCT05651932

AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)

被験者募集中第1/2相

Research Site, Miami

18歳以上 · 全性別 · 2026/08/17更新 · NCT05850234

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

被験者募集中第1相

University of Miami, Miami

18歳以上 · 全性別 · 2026/08/12更新 · NCT07280013

Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)

被験者募集中第4相

Sylvester Comprehensive Cancer Center, Miami
University of Miami Hospital and Clinics - Griffin Cancer Research Building, Miami
University of Miami Hospital and Clinics, Miami

18歳以上 · 全性別 · 2026/07/01更新 · NCT06057402